Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.01% Atropine for NITM and Myopic Progression
NCT06034366Unknown
- Sponsor
- He Eye Hospital
- Start
- Oct 2023
- Primary completion
- May 2025
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in myopia comparing 0.01% Atropine with Placebo (2 arms). Primary endpoint: Nearwork-induced transient myopia at 48 weeks. Status: unknown.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT06034366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06034366.